Trial Profile
A multicenter, open label, non-randomised phase II study with induction chemotherapy with Cisplatin and 5-fluorouracil as combined with accelerated radiotherapy and Erbitux for locally advanced unresectable squamous cell carcinoma.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 07 Jun 2011
Price :
$35
*
At a glance
- Drugs Cetuximab (Primary) ; Cisplatin; Fluorouracil
- Indications Head and neck cancer; Hypopharyngeal cancer; Laryngeal cancer; Oropharyngeal cancer
- Focus Therapeutic Use
- Acronyms Accrobat
- 07 Jun 2011 New trial record